Cryopreservation Media

Cryopreservation Media Market Outlook

The global cryopreservation media market is projected to reach approximately USD 6.8 billion by 2035, growing at a CAGR of 9.5% during the forecast period from 2025 to 2035. The increasing prevalence of infertility, advancements in biobanking, and the burgeoning demand for stem cell research are driving market expansion. Additionally, the rising investments in regenerative medicine and cell therapies are contributing significantly to the growth of the cryopreservation media market. The need for effective preservation techniques for biological samples in both clinical and research settings is further catalyzing the demand for these specialized media. Moreover, the evolution of new and improved cryoprotectants and preservation techniques is enhancing the efficiency of cryopreservation processes.

Growth Factor of the Market

The growth of the cryopreservation media market is primarily influenced by several key factors including the increasing demand for assisted reproductive technologies (ART), advancements in stem cell research, and the growing need for biobanking solutions. As infertility rates continue to rise globally, more couples are seeking ART solutions, which in turn boosts the demand for effective cryopreservation media. Furthermore, ongoing research in regenerative medicine, where stem cells play an essential role, is propelling the need for specialized media that can preserve these cells without compromising their viability. Additionally, increasing awareness and investments in biobanking practices for both clinical and research purposes are significantly contributing to the market growth. The advent of innovative cryoprotectants is also enhancing the potential of cryopreservation techniques, making the process more efficient and reliable.

Key Highlights of the Market

• Projected market size of USD 6.8 billion by 2035, with a CAGR of 9.5% from 2025 to 2035.
• Increased adoption of assisted reproductive technologies driving demand.
• Growth in regenerative medicine and stem cell research fueling the market.
• Emergence of innovative cryoprotectants improving preservation efficiency.
• Growing awareness and investment in biobanking practices enhancing market prospects.

By Product Type

Sera-based Media:

Sera-based media are widely used in cryopreservation due to their ability to provide essential nutrients and hormones necessary for cell survival and growth. This type of media contains a variety of proteins and growth factors derived from animal serum, which help to minimize cellular damage during the freezing process. The demand for sera-based media is particularly high in applications involving stem cells and reproductive cells, as these cells require a nutrient-rich environment to maintain their viability and functionality post-thawing. However, the use of animal-derived components raises concerns regarding quality control and consistency, pushing research towards developing serum-free alternatives.

Serum-free Media:

Serum-free media represent a significant segment within the cryopreservation media market, driven by the need for standardized and consistent preservation methods. These media are formulated without any animal-derived products, thereby eliminating risks related to contamination and variability in serum quality. They provide a controlled environment for cell preservation, making them particularly suitable for applications in biotechnology and pharmaceutical research. The increasing focus on developing ethical and sustainable practices in research and development contributes to the rising adoption of serum-free media, as they align with the growing demand for animal-free solutions.

Protein-based Media:

Protein-based media are formulated with specific proteins that serve as cryoprotectants, providing stability and reducing ice crystal formation during the freezing process. These media are favorable for preserving various cell types, including stem cells, as they can enhance cell membrane integrity and promote higher survival rates post-thawing. The growing emphasis on precision medicine and personalized therapies has generated heightened interest in protein-based media, as they can be tailored to meet the unique requirements of different cell lines. The versatility and enhanced performance of protein-based media are expected to drive their adoption within research and clinical settings.

Chemically Defined Media:

Chemically defined media are increasingly gaining traction in the cryopreservation market due to their precise composition and ability to provide consistent results. These media are designed with specific concentrations of nutrients, amino acids, and growth factors, ensuring optimal conditions for cell preservation without the variability associated with serum-based approaches. The stringent quality control and reproducibility offered by chemically defined media are particularly beneficial for applications that demand high standards, such as regenerative medicine and cell therapy. As researchers strive for reproducibility and reliability in their experiments, the emphasis on chemically defined media is likely to grow further.

Specialty Media:

Specialty media are tailored formulations designed for specific cell types or applications, providing targeted support for unique preservation needs. These media often contain unique additives or growth factors that cater to the requirements of specialized cells, such as germ cells or immune cells. The demand for specialty media is expected to rise as research progresses into niche areas such as cancer immunotherapy, where specific cell types require meticulous preservation techniques. Innovations in specialty media will continue to enhance the cryopreservation landscape, supporting advancements across various fields of cell biology and regenerative medicine.

By Application

Stem Cells:

The application of cryopreservation media in stem cell research is one of the most critical segments of the market. Stem cells are unique in their ability to differentiate into various cell types, making their preservation crucial for research and therapeutic applications. Cryopreservation allows researchers to store stem cells for extended periods without losing their viability and functionality post-thaw. As stem cell therapies gain traction in treating chronic diseases and injuries, the demand for specialized cryopreservation media tailored for these cells will continue to rise, fueling significant growth in this segment.

Biobanking:

Biobanking is the process of collecting, storing, and preserving biological samples for future research, and cryopreservation media play an essential role in this process. High-quality biological samples are crucial for various research activities, including disease studies and drug development. The global biobanking market is witnessing substantial growth, driven by increasing research activities and the need for personalized medicine. Effective cryopreservation media ensure the integrity and longevity of samples, thereby enhancing the reliability of research findings. As public awareness of biobanking grows and more institutions establish biobanks, the demand for cryopreservation media will continue to expand.

Assisted Reproductive Technology:

Assisted reproductive technology (ART) is another prominent application segment for cryopreservation media, particularly for the preservation of oocytes, sperm, and embryos. The rise in infertility rates and the increasing acceptance of ART procedures worldwide are driving the demand for effective cryopreservation techniques. Specialized media are essential for maintaining the viability of reproductive cells during the freezing and thawing processes, thereby improving success rates in fertility treatments. As more couples seek ART options, the reliance on advanced cryopreservation media will significantly contribute to the market's growth.

Cell Line Preservation:

Cell line preservation through cryopreservation is crucial for the biotechnology and pharmaceutical sectors, where maintaining cell line integrity is essential for ongoing research and development. Cryopreservation media support the long-term storage of established cell lines, ensuring they remain viable for future studies. The increasing reliance on cell lines for drug development, toxicity testing, and vaccine production is driving the demand for effective cryopreservation solutions. As research in biotechnology advances, the need for reliable cell line preservation will continue to enhance the role of cryopreservation media.

Organ Preservation:

Organ preservation is an emerging application area where cryopreservation media are gaining importance. The ability to preserve organs for transplantation is critical in increasing the success rates of transplant procedures. Cryopreservation allows for extended storage of organs, reducing the risk of ischemic damage and improving overall transplant outcomes. As organ donation rates fluctuate and the demand for transplantable organs rises, effective cryopreservation methods will be essential. The advancements in organ preservation techniques will further spur the growth of the cryopreservation media market.

By End User

Biotechnology & Pharmaceutical Companies:

Biotechnology and pharmaceutical companies are major end users of cryopreservation media, utilizing them for research, development, and production of therapeutic products. These companies rely on high-quality cryopreservation techniques to maintain the viability of various cells, including stem cells and cell lines, which are essential for drug discovery and development processes. The increasing focus on biopharmaceuticals and personalized medicine is driving the demand for effective cryopreservation solutions within these industries. As companies strive for innovation and efficiency in their processes, the reliance on advanced cryopreservation media will further solidify their market position.

Academic & Research Institutes:

Academic and research institutes play a pivotal role in the cryopreservation media market, conducting extensive research in cellular biology, regenerative medicine, and biotechnology. These institutions require effective cryopreservation methods to preserve biological samples and cell lines for ongoing research initiatives. The growth in funding for scientific research and the increasing number of research projects focusing on cell therapies and regenerative medicine contribute to the demand for cryopreservation media in academic settings. As research continues to evolve and expand, the need for reliable preservation techniques will remain a priority for these institutions.

Hospitals & Clinics:

Hospitals and clinics are significant end users of cryopreservation media, particularly in the context of reproductive health services and fertility treatments. The increasing prevalence of infertility and the growing acceptance of assisted reproductive technologies necessitate the use of effective cryopreservation methods to maintain the viability of reproductive cells. Hospitals and fertility clinics are investing in advanced cryopreservation media to improve success rates in ART procedures, further driving the demand in this segment. As more healthcare facilities adopt cryopreservation practices, the market for cryopreservation media within hospitals and clinics is expected to grow.

Cell Banks & Regenerative Medicine Centers:

Cell banks and regenerative medicine centers are prominent users of cryopreservation media for storing various types of cells, including stem cells and immune cells. These facilities require specialized media to ensure the long-term viability of stored cells, which are critical for research and therapeutic applications. The increasing focus on regenerative medicine and cell therapy is driving the establishment of more cell banks, resulting in heightened demand for effective cryopreservation solutions. As the field of regenerative medicine advances, the reliance on high-quality cryopreservation media will continue to expand.

Contract Research Organizations:

Contract research organizations (CROs) are increasingly utilizing cryopreservation media in their research services, providing support for drug development and clinical trials. CROs require reliable cryopreservation techniques to store biological samples, ensuring their integrity for various studies. The growing trend of outsourcing research activities to CROs is driving demand for cryopreservation media as these organizations strive to deliver high-quality results for their clients. As the pharmaceutical industry continues to evolve and companies seek to streamline their research processes, the reliance on CROs and their use of cryopreservation media will likely increase.

By Cryoprotectant Type

Dimethyl Sulfoxide:

Dimethyl sulfoxide (DMSO) is one of the most commonly used cryoprotectants in cryopreservation media. Known for its ability to penetrate cell membranes effectively, DMSO helps to protect cells from ice crystal formation during the freezing process. Its unique properties make it particularly valuable for preserving a wide range of cell types, including stem cells and reproductive cells. The rising preference for DMSO as an effective cryoprotectant is driven by its proven efficacy in various cryopreservation applications, ensuring higher cell viability and functionality post-thawing.

Glycerol:

Glycerol is another widely used cryoprotectant that plays a critical role in the preservation of biological samples. It functions by stabilizing cell membranes and preventing damage caused by ice crystal formation during the freezing process. Glycerol is particularly beneficial for preserving sperm and oocytes, making it a popular choice in assisted reproductive technology applications. As the demand for effective cryopreservation solutions continues to rise, glycerol will maintain its significance in the market due to its proven efficiency and compatibility with various cell types.

Ethylene Glycol:

Ethylene glycol is a versatile cryoprotectant known for its low toxicity and effective performance in cryopreservation. It is commonly used in combination with other cryoprotectants to enhance the preservation process for various cell types. Ethylene glycol works by reducing the freezing point of the media, thereby minimizing the risk of ice crystal formation that can cause cellular damage. As research progresses and the need for effective cryopreservation techniques grows, ethylene glycol will continue to be a popular choice among scientists and researchers for preserving sensitive biological samples.

Sucrose:

Sucrose serves as an osmotic stabilizer in cryopreservation media, helping to protect cells during the freezing and thawing processes. Its low toxicity and ability to prevent cellular dehydration make sucrose an ideal option for preserving various cell types, particularly in regenerative medicine and stem cell research. As researchers continue to explore the most effective preservation techniques, the incorporation of sucrose in cryopreservation media will likely increase, further enhancing the viability of preserved cells.

Polyvinylpyrrolidone:

Polyvinylpyrrolidone (PVP) is a synthetic polymer that acts as a cryoprotectant in various cryopreservation applications. Its unique properties enable it to stabilize cell membranes and prevent ice crystal formation during the freezing process. PVP is particularly beneficial for preserving sensitive cell types, such as stem cells and primary cells, which require optimal conditions for long-term storage. As advancements in cryopreservation techniques continue to emerge, the role of PVP as a cryoprotectant will remain significant in ensuring high cell viability rates post-thawing.

By Region

The North America cryopreservation media market is currently the largest, accounting for approximately 45% of the total market share. The region's growth is primarily driven by the increasing prevalence of infertility, advancements in assisted reproductive technologies, and a robust research environment in regenerative medicine. Furthermore, significant investments in biotechnology and pharmaceutical sectors have led to heightened demand for effective cryopreservation solutions. The North American market is expected to grow at a CAGR of 8.8% from 2025 to 2035, fueled by continuous innovations in cryopreservation techniques and products.

Europe holds a substantial share in the cryopreservation media market, representing around 30% of the total market. The region's growth is supported by the rising number of fertility clinics and biobanks, coupled with an increasing emphasis on research and development in biomedical sciences. Countries such as Germany, the United Kingdom, and France are at the forefront of advancements in cryopreservation technologies, contributing to the market's expansion. As awareness of assisted reproductive technologies and biobanking continues to grow in Europe, the demand for cryopreservation media is anticipated to see significant growth during the forecast period.

Opportunities

The cryopreservation media market presents numerous opportunities as advancements in biotechnology and regenerative medicine are rapidly evolving. One of the most significant opportunities lies in the development of next-generation cryopreservation media that incorporate novel cryoprotectants designed to enhance cell viability during the freezing and thawing processes. This includes research focusing on naturally derived cryoprotectants and innovative formulations that minimize cellular stress. Additionally, as the global demand for stem cell therapies increases, there is a growing need for specialized cryopreservation media tailored to the unique requirements of stem cells, further driving market expansion. Furthermore, collaborations between biotechnology companies and research institutions can lead to the development of cutting-edge solutions that cater to emerging applications in regenerative medicine.

Moreover, the increasing focus on personalized medicine indicates a promising opportunity for cryopreservation media manufacturers. As healthcare transitions towards personalized therapies, the need for effective preservation techniques to store unique biological samples will become paramount. This shift is anticipated to drive demand for custom formulations that meet specific patient needs, allowing for improved outcomes in treatments involving stem cells and other cell types. Additionally, the growing trend in biobanking for both clinical and research applications will further enhance market potential, as effective cryopreservation solutions are essential for maintaining sample integrity. Overall, the convergence of technological advancements and growing healthcare demands presents diverse opportunities for stakeholders in the cryopreservation media market.

Threats

Despite its promising growth, the cryopreservation media market faces several threats that could potentially hinder its expansion. The regulatory landscape surrounding the use of biological materials and cryopreservation techniques can be stringent and complex. Compliance with these regulations may pose challenges for manufacturers, leading to increased operational costs and longer time-to-market for new products. Furthermore, the presence of alternative preservation techniques, such as vitrification, could potentially impact the demand for traditional cryopreservation media. As researchers explore more advanced methods for preserving biological samples, there may be a shift in preference away from conventional cryopreservation approaches, posing a challenge for market players.

Additionally, the high costs associated with cryopreservation media and related technologies could limit their accessibility, particularly in regions with lower healthcare budgets. This disparity in access may create a divide in the adoption of cryopreservation solutions, particularly in developing countries where there is a growing need for advanced preservation techniques. Furthermore, competition among key players in the market can lead to pricing pressures, further complicating the landscape for smaller manufacturers. As the market continues to evolve, addressing these threats will be crucial for stakeholders aiming to maintain a competitive edge in the cryopreservation media market.

Competitor Outlook

• Thermo Fisher Scientific
• Gibco (a part of Thermo Fisher Scientific)
• Merck KGaA
• Sigma-Aldrich
• BD Biosciences
• Lonza Group
• STEMCELL Technologies
• Revotek Co., Ltd.
• Cleveland BioLabs, Inc.
• ReproCELL Inc.
• Ge Healthcare
• Cell Culture Technologies, Inc.
• BioLife Sciences Inc.
• R&D Systems, Inc.
• Fertility Preservation, LLC

The competitive landscape of the cryopreservation media market is characterized by a mix of established players and emerging companies striving to innovate and cater to the evolving needs of the market. Major players like Thermo Fisher Scientific and Merck KGaA dominate the market, leveraging their extensive product portfolios, robust distribution networks, and significant investments in research and development. These companies focus on enhancing their cryopreservation media offerings by incorporating advanced cryoprotectants and developing specialized formulations tailored for diverse applications. Moreover, strategic partnerships and collaborations are common strategies employed by these organizations to expand their market presence and enhance their product offerings.

Emerging companies and smaller players are also entering the market, focusing on niche areas within the cryopreservation space. They often aim to provide innovative solutions that cater to specific requirements, such as the development of serum-free and chemically defined media, which address concerns regarding quality control and consistency. These companies can capitalize on the growing trend towards personalized medicine and the increasing demand for ethically sourced biological materials. As the market dynamics shift, innovation will remain a key driver of competition, with companies striving to differentiate their products through advancements in formulation and technology.

Some notable competitors include BD Biosciences, known for its extensive range of cryopreservation products catering to various cell types, and Lonza Group, which focuses on developing specialized media for regenerative medicine applications. Additionally, STEMCELL Technologies is recognized for its commitment to providing high-quality cell culture solutions, including cryopreservation media. These companies, along with others, are actively involved in research and development efforts, continuously working towards enhancing the effectiveness of cryopreservation techniques. As the cryopreservation media market continues to evolve, the competitive landscape will likely remain dynamic, with both established and emerging players striving to capture market share and meet the growing demand for effective preservation solutions.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Merck KGaA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Lonza Group
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Ge Healthcare
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Sigma-Aldrich
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 BD Biosciences
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 ReproCELL Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 R&D Systems, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Revotek Co., Ltd.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 BioLife Sciences Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 STEMCELL Technologies
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Cleveland BioLabs, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Thermo Fisher Scientific
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Fertility Preservation, LLC
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Cell Culture Technologies, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Gibco (a part of Thermo Fisher Scientific)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Cryopreservation Media Market, By End User
    • 6.1.1 Biotechnology & Pharmaceutical Companies
    • 6.1.2 Academic & Research Institutes
    • 6.1.3 Hospitals & Clinics
    • 6.1.4 Cell Banks & Regenerative Medicine Centers
    • 6.1.5 Contract Research Organizations
  • 6.2 Cryopreservation Media Market, By Application
    • 6.2.1 Stem Cells
    • 6.2.2 Biobanking
    • 6.2.3 Assisted Reproductive Technology
    • 6.2.4 Cell Line Preservation
    • 6.2.5 Organ Preservation
  • 6.3 Cryopreservation Media Market, By Product Type
    • 6.3.1 Sera-based Media
    • 6.3.2 Serum-free Media
    • 6.3.3 Protein-based Media
    • 6.3.4 Chemically Defined Media
    • 6.3.5 Specialty Media
  • 6.4 Cryopreservation Media Market, By Cryoprotectant Type
    • 6.4.1 Dimethyl Sulfoxide
    • 6.4.2 Glycerol
    • 6.4.3 Ethylene Glycol
    • 6.4.4 Sucrose
    • 6.4.5 Polyvinylpyrrolidone

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Cryopreservation Media Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Cryopreservation Media market is categorized based on

By Product Type

• Sera-based Media
• Serum-free Media
• Protein-based Media
• Chemically Defined Media
• Specialty Media

By Application

• Stem Cells
• Biobanking
• Assisted Reproductive Technology
• Cell Line Preservation
• Organ Preservation

By End User

• Biotechnology & Pharmaceutical Companies
• Academic & Research Institutes
• Hospitals & Clinics
• Cell Banks & Regenerative Medicine Centers
• Contract Research Organizations

By Cryoprotectant Type

• Dimethyl Sulfoxide
• Glycerol
• Ethylene Glycol
• Sucrose
• Polyvinylpyrrolidone

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Gibco (a part of Thermo Fisher Scientific)
• Merck KGaA
• Sigma-Aldrich
• BD Biosciences
• Lonza Group
• STEMCELL Technologies
• Revotek Co., Ltd.
• Cleveland BioLabs, Inc.
• ReproCELL Inc.
• Ge Healthcare
• Cell Culture Technologies, Inc.
• BioLife Sciences Inc.
• R&D Systems, Inc.
• Fertility Preservation, LLC